DataCite
metadata only
Improving Immunogenicity of Subunit Vaccines Using Nanocarrier Systems
New generation vaccines, which are subunit vaccines, have considerably improved safety profiles, but are often poorly immunogenic, especially when administered through mucosal routes. Also, the diversity of the mechanisms of action of infectious pathogens requires the tuning of vaccine formulations
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Next-generation vaccine adjuvants: Integrating nanotechnology, systems immunology, and computational approaches for precision vaccinology#642691
- A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults#28409
- Role of nanoparticles and nano-oxide particles in vaccine development#459436
- A review of vaccine adjuvants in modern immunology: Mechanisms, classes, and advances in next generation vaccine design: Adjuvants vaccinaux en immunologie moderne: Mécanismes, classes et avancées dans la conception des vaccins de nouvelle generation#1149013
- Artificial recombinant high-density protein nanocarriers for precision drug delivery.#288731
Record · ID 1361785
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive